A detailed history of Massmutual Trust CO Fsb transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 52 shares of ITCI stock, worth $4,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$4,432
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$64.76 - $79.84 $323 - $399
5 Added 10.64%
52 $3,000
Q1 2024

Apr 09, 2024

BUY
$64.37 - $75.65 $128 - $151
2 Added 4.44%
47 $3,000
Q4 2023

Jan 03, 2024

SELL
$46.37 - $73.65 $510 - $810
-11 Reduced 19.64%
45 $3,000
Q3 2023

Oct 03, 2023

BUY
$52.09 - $64.1 $677 - $833
13 Added 30.23%
56 $2,000
Q3 2022

Oct 07, 2022

BUY
$42.7 - $59.99 $469 - $659
11 Added 34.38%
43 $2,000
Q1 2022

Apr 08, 2022

BUY
$38.74 - $62.09 $774 - $1,241
20 Added 166.67%
32 $2,000
Q4 2021

Feb 09, 2022

BUY
$35.2 - $53.42 $422 - $641
12 New
12 $1,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.05B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.